We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP) (ALGODREP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04076683
Recruitment Status : Unknown
Verified August 2019 by Etablissement Français du Sang.
Recruitment status was:  Not yet recruiting
First Posted : September 3, 2019
Last Update Posted : September 3, 2019
Assistance Publique - Hôpitaux de Paris
Université Paris Est Créteil
Information provided by (Responsible Party):
Etablissement Français du Sang

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2021